Add to ORKGHuman papillomavirus (HPV), the most common sexually transmitted infection in the US and worldwide, can cause cancers, anogenital warts (AGW), and recurrent respiratory papillomatosis (RRP) in men, women, and children. Global incidence of AGW ranges from 160-289 cases per 100,000 person-years and peaks in young men and women in the third decade of life. RRP has an estimated incidence of 3 per 1 million person-years in children. Pre-licensure trial efficacy, modeling and time-trend ecological studies have shown a significant short-term impact of 4vHPV vaccine. In girls aged 15-19 years, a previously published meta-analysis indicated that genital warts decreased significantly by 31%; stratified analysis revealed more substantial reductions in...
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiati...
BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics ...
Background There is ongoing debate about the possible protective effect of the bivalent human papill...
Background More than ten years have elapsed since human papillomavirus (HPV) vaccination was impleme...
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16...
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16...
Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemen...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Human papillomavirus (HPV) vaccination programs were first implemented in 2007. We conducted a syste...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16...
BackgroundThe incidence of anogenital warts (AGW) decreased after the introduction of the quadrivale...
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiati...
BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics ...
Background There is ongoing debate about the possible protective effect of the bivalent human papill...
Background More than ten years have elapsed since human papillomavirus (HPV) vaccination was impleme...
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16...
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16...
Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemen...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Human papillomavirus (HPV) vaccination programs were first implemented in 2007. We conducted a syste...
Background. There is ongoing debate about the possible protective effect of the bivalent human papil...
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16...
BackgroundThe incidence of anogenital warts (AGW) decreased after the introduction of the quadrivale...
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public health initiati...
BACKGROUND: For several decades, diagnoses of genital warts at genitourinary medicine (GUM) clinics ...
Background There is ongoing debate about the possible protective effect of the bivalent human papill...